Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Hamme-Mille – page 20

1 947 clinical trials in Hamme-Mille, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hamme-Mille at a glance
1 947
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 947 trials in Hamme-Mille

Open in trial search

A study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:AstraZeneca AB

Pouchitis

Recruiting

Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:UZ Leuven

A study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Vasigrobart
  • Sponsor:Regeneron Pharmaceuticals Inc.

A study of YL201 and atezolizumab for patients with advanced solid tumors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Medilink Therapeutics (Suzhou) Co. Ltd.

A study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil
  • Sponsor:Liquidia Technologies Inc.

A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Hidradenitis

Recruiting

A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:SAR445399
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim International GmbH

Cancer pain

Recruiting

Comparing ziconotide and a drug combination to standard medical management for patients with severe cancer pain

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bupivacaine Hydrochloride, Anhydrous
  • Sponsor:Vrije Universiteit Brussel

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Hamme-Mille

What the registry says about research in the country

01 Viral Infections & Dermatology

Clinical research focusing on recurrent orofacial herpes and non-genital wart treatments, evaluating innovative therapeutic approaches for common viral skin conditions.

  • Herpes Management Study
  • Wart Treatment Evaluation

These trials aim to assess the effectiveness of specialized treatments in reducing infection recurrence and promoting lesion clearance.

02 Treatment Efficacy Studies

Comprehensive evaluation of therapeutic interventions through placebo-controlled trials, focusing on long-term effectiveness and patient outcomes.

  • 12-month Episode Reduction Analysis
  • Comparative Treatment Assessment

Research protocols designed to measure treatment success rates and duration of therapeutic effects.

03 Clinical Research Methodology

Implementation of double-blind randomized studies to ensure unbiased evaluation of treatment efficacy in dermatological conditions.

  • Placebo-Controlled Protocols
  • Treatment Duration Analysis

Structured research approaches examining both pediatric and adult treatment formulations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.